Paul Tudor Jones’s Cano Health, Inc. CANO Stock Holding History

Paul Tudor Jones’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-126	Closed	-$160K	–	3161
2021 Q3	$160K	Buy	+126	New	+$153K	﹤0.01%	2334

Other funds holding CANO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Paul Tudor Jones's CANO Position: Q4 2023 in Review

Paul Tudor Jones sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 6,117 shares — an estimated $155K sold.

Paul Tudor Jones first reported a position in CANO in Q3 2020 and held it in 9 quarters. The position peaked at $2.08M in Q3 2020. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

Paul Tudor Jones reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
Paul Tudor Jones sold 6,117 Cano Health, Inc. shares in Q4 2023, an estimated $155K.
Paul Tudor Jones first reported a position in Cano Health, Inc. in Q3 2020 and held it in 9 quarters.
Paul Tudor Jones's Cano Health, Inc. position peaked at $2.08M in Q3 2020.
50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Tudor Investment Corp's 13F filing for Q4 2023, filed 14 Feb 2024.